Financhill
Sell
40

FCX Quote, Financials, Valuation and Earnings

Last price:
$37.17
Seasonality move :
1.15%
Day range:
$36.74 - $37.55
52-week range:
$27.66 - $55.24
Dividend yield:
1.61%
P/E ratio:
30.72x
P/S ratio:
2.16x
P/B ratio:
2.94x
Volume:
11.2M
Avg. volume:
21.6M
1-year change:
-29.08%
Market cap:
$52B
Revenue:
$25.5B
EPS (TTM):
$1.21

Analysts' Opinion

  • Consensus Rating
    Freeport-McMoRan has received a consensus rating of Buy. The company's average rating is a Buy based on 9 Buy ratings, 6 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $44.71, Freeport-McMoRan has an estimated upside of 20.27% from its current price of $37.17.
  • Price Target Downside
    According to analysts, the lowest downside price target is $26.00 representing 30.05% downside risk from its current price of $37.17.

Fair Value

  • According to the consensus of 15 analysts, Freeport-McMoRan has 20.27% upside to fair value with a price target of $44.71 per share.

FCX vs. S&P 500

  • Over the past 5 trading days, Freeport-McMoRan has overperformed the S&P 500 by 7.64% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Freeport-McMoRan does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Freeport-McMoRan revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Freeport-McMoRan reported revenues of $5.7B.

Earnings Growth

  • Freeport-McMoRan earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Freeport-McMoRan reported earnings per share of $0.24.
Enterprise value:
68.6B
EV / Invested capital:
1.78x
Price / LTM sales:
2.16x
EV / EBIT:
10.05x
EV / Revenue:
2.76x
PEG ratio (5yr expected):
4.34x
EV / Free cash flow:
42.97x
Price / Operating cash flow:
33.64x
Enterprise value / EBITDA:
7.67x
Gross Profit (TTM):
$7.3B
Return On Assets:
3.21%
Net Income Margin (TTM):
7.11%
Return On Equity:
6.15%
Return On Invested Capital:
4.64%
Operating Margin:
22.75%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Income Statement
Revenue $21.6B $23.8B $24.9B $6.3B $5.7B
Gross Profit $6.6B $7.2B $7.3B $1.9B $1.5B
Operating Income $5.8B $6.3B $6.5B $1.6B $1.3B
EBITDA $8.1B $8.9B $8.9B $2.4B $1.8B
Diluted EPS $1.79 $1.13 $1.21 $0.32 $0.24
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Balance Sheet
Current Assets $10.9B $15.3B $14.7B $14.8B $13.8B
Total Assets $43.6B $48.8B $50.9B $54.2B $56B
Current Liabilities $4.6B $6.5B $5.3B $6.3B $5.9B
Total Liabilities $24.1B $24.8B $25.3B $26.1B $26.8B
Total Equity $19.6B $24B $25.6B $28.1B $29.2B
Total Debt $9.8B $9.6B $9.6B $9.4B $9.4B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Cash Flow Statement
Cash Flow Operations $4.5B $6.1B $6.3B $1.9B $1.1B
Cash From Investing -$3.9B -$5.1B -$4.9B -$1.3B -$1.2B
Cash From Financing -$2.1B -$1.8B -$2.8B -$342M $155M
Free Cash Flow $631M $1.2B $1.6B $642M -$114M
FCX
Sector
Market Cap
$52B
$18M
Price % of 52-Week High
67.29%
62.5%
Dividend Yield
1.61%
0%
Shareholder Yield
--
1.27%
1-Year Price Total Return
-29.08%
-15.52%
Beta (5-Year)
1.710
0.917
Dividend yield:
1.61%
Annualized payout:
$0.60
Payout ratio:
48.93%
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $35.56
200-day SMA
Sell
Level $41.78
Bollinger Bands (100)
Sell
Level 35.05 - 41.13
Chaikin Money Flow
Buy
Level 706.9M
20-day SMA
Buy
Level $34.10
Relative Strength Index (RSI14)
Buy
Level 55.59
ADX Line
Buy
Level 17.74
Williams %R
Sell
Level -8.161
50-day SMA
Buy
Level $36.80
MACD (12, 26)
Sell
Level -0.05
25-day Aroon Oscillator
Sell
Level -32
On Balance Volume
Neutral
Level 1.6B

Financial Scores

Hold
Altman Z-Score (Annual)
Level (2.3245)
Sell
CA Score (Annual)
Level (-0.5023)
Buy
Beneish M-Score (Annual)
Level (-3.2747)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-2.0244)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Freeport-McMoRan owns stakes in 10 copper mines, led by its 49% ownership of the Grasberg copper and gold operations in Indonesia, 55% of the Cerro Verde mine in Peru, and 72% of Morenci in Arizona. It sold around 1.2 million metric tons of copper (its share) in 2024, making it the one of the world’s largest copper miners by volume. It also sold about 900,000 ounces of gold, mostly from Grasberg, and 70 million pounds of molybdenum. It had about 25 years of copper reserves at the end of December 2024. We expect it to sell similar amounts of copper midcycle in 2029, though we expect gold volumes to decline to about 700,000 ounces then due to falling production at Grasberg.

Stock Forecast FAQ

In the current month, FCX has received 9 Buy ratings 6 Hold ratings, and 0 Sell ratings. The FCX average analyst price target in the past 3 months is $44.71.

  • Where Will Freeport-McMoRan Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Freeport-McMoRan share price will rise to $44.71 per share over the next 12 months.

  • What Do Analysts Say About Freeport-McMoRan?

    Analysts are divided on their view about Freeport-McMoRan share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Freeport-McMoRan is a Sell and believe this share price will drop from its current level to $26.00.

  • What Is Freeport-McMoRan's Price Target?

    The price target for Freeport-McMoRan over the next 1-year time period is forecast to be $44.71 according to 15 Wall Street analysts, 9 of them rate the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.

  • Is FCX A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Freeport-McMoRan is a Buy. 9 of 15 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of FCX?

    You can purchase shares of Freeport-McMoRan via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Freeport-McMoRan shares.

  • What Is The Freeport-McMoRan Share Price Today?

    Freeport-McMoRan was last trading at $37.17 per share. This represents the most recent stock quote for Freeport-McMoRan. Yesterday, Freeport-McMoRan closed at $37.17 per share.

  • How To Buy Freeport-McMoRan Stock Online?

    In order to purchase Freeport-McMoRan stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Okta Stock Finally Gaining Investor Confidence?
Is Okta Stock Finally Gaining Investor Confidence?

Given how digital transformation has proliferated, cyberattacks have also been…

Is The Trade Desk the Best Advertising Stock Now?
Is The Trade Desk the Best Advertising Stock Now?

The worldly backdrop is now shrouded in heavy uncertainty and…

Is it Too Late to Buy Gold?
Is it Too Late to Buy Gold?

Amid deep uncertainties about the future of the US economy,…

Stock Ideas

Buy
59
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
58
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
55
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Buy
85
HIMS alert for Apr 30

Hims & Hers Health [HIMS] is up 23.1% over the past day.

Sell
35
RGC alert for Apr 30

Regencell Bioscience Holdings [RGC] is down 11.18% over the past day.

Buy
54
EAT alert for Apr 30

Brinker International [EAT] is down 14.88% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock